Text Size

Paroxetine markedly increases plasma concentrations of ophthalmic timolol; cyp2d6 inhibitors may increase the risk of cardiovascular adverse effects of 0.5% timolol eye drops

Mäenpää J., Volotinen-Maja M., Kautiainen H., Neuvonen M., Niemi M., Neuvonen P.J., Backman J.T.


  • 2014
  • Drug Metabolism and Disposition
View publication
  • Therapeutic Area

    Glaucoma

  • Categories

    Clinical development

  • Affiliations

    Santen Oy, Tampere, Finland; Medcare Oy, Äänekoski, Finland; Department of Clinical Pharmacology, University of Helsinki, Helsinki University Central Hospital, P.O. Box 705, HUS, Helsinki, FI- 00029, Finland

Related Publications

Assessment of Brain-Derived Neurotrophic Factor on Retinal Structure and Visual Function in Rodent Models of Optic Nerve Crush

Taniguchi T.; Sharif N.A.; Ota T.; Farjo R.A.; Rausch R.


24-Hour Evaluation of the Effectiveness and Tolerability of Preservative-Free Tafluprost-Timolol Fixed Combination in Open-Angle Glaucoma or Ocular Hypertensive Patients Previously Treated with Preserved Latanoprost

Oddone F, Tanga L, Giammaria S, Sabbatini L, Strianese A, Ferrazza M, Rossetti LM


MicroRNA profile of extracellular vesicles released by Müller glial cells

Lamb W D.B.; Eastlake K.; Luis J.; Sharif N.A. ; Khaw P. T.; Limb G. A.


Can't find what you're looking for?

Contact us

Document number: NP-No product-EMEA-0110
Date of preparation: February 2022